Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Details Narrative)

v3.7.0.1
Fair Value Measurements (Details Narrative) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 21, 2017
Jun. 16, 2017
Dec. 31, 2016
Jun. 21, 2016
Business combination, contingent consideration liabilities $ 235     $ 260  
Prefunded Warrants [Member]          
Warrant to purchase shares of common stock   2,600,000 2,600,000    
Underwriter Warrants[Member]          
Warrant to purchase shares of common stock   575,000     1,875,000
RedPath Integrated Pathology, Inc [Member] | Termination Agreement [Member]          
Business combination, contingent consideration liabilities 6,000        
Business combination, operating expenses $ 5,800